Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Baricitinib is effective and safe for treating severe alopecia areata.

Sunlight worsens hair loss; protect scalp.

PLGA-based microneedles are promising for safe and effective skin delivery of drugs and vaccines.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Vitamins A, B3, C, D, and E can improve skin health and immunity.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.